Table 4.

Pathological Staging

	All patients (n=257)		Group 1 Patients with nodes < 15 (n=129)		Group 2 Patients with nodes ≥ 15 (n=128)		p – value <15 vs. >15 nodes examined
	n or median	% or range	n or median	% or range	n or median	% or range
AJCC/UICC T status							0.0148
T1	40	15.6	29	22.5	11	8.6
T2	71	27.6	30	23.3	41	32
T3	119	46.3	58	45	61	47.7
T4	26	10.1	11	8.5	15	11.7
Unavailable	1	0.4	1	0.8	0	0
AJCC/UICC N status							<0.0001
N0	85	33.1	58	45.0	27	21.1
N1	90	35.0	56	43.4	34	26.6
N2	58	22.6	15	11.6	43	33.6
N3	24	9.3	0	0	24	18.8
N ratio (mean)	0.21	0–1.0	0.08	0–1.0	0.35	0–1.0	0.0036
Node ratio intervals							<0.0001
Nr 0	28	10.9	N/A	N/A	28	21.9
Nr 1	111	43.2	80	62	31	24.2
Nr 2	62	24.1	24	18.6	38	29.7
Nr 3	49	19.1	18	14	31	24.2
Unavailable	7	2.7	7	5.4	0	0
AJCC/UICC M status							0.532
MO	207	80.5	106	82.2	101	78.9
M1	50	19.5	23	17.8	27	21.1
AJCC TNM Stage							0.0234
I	67	26.1	42	32.6	25	19.5
II	44	17.1	27	20.9	17	13.3
III	75	29.2	32	24.8	43	33.6
IV	70	27.2	27	20.9	43	33.6
Unavailable	1	0.4	1	0.8	0	0